Compare TransMedics Group Inc (TMDX) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs ProShares Ultra Gold ETF — how do they compare? TransMedics Group Inc trades at $86.5 (market cap $3.00B), while ProShares Ultra Gold ETF trades at $51.27. Which is the better fit depends on your goals.
| TMDX | UGL | |
|---|---|---|
Market Cap | $3.00B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $150.42 | $85.62 |
52-Week Low | $61.99 | $41.14 |
Enterprise Value | $3.39B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 results with $605M revenue and 31.4% net margin, though 2026 projections show margin compression. Recent news highlights growth initiatives in kidney transplantation and European markets, alongside ongoing legal investigations into fiduciary duties.
The stock offers upside to the $99.57 consensus price target, supported by analyst bullishness (69% buy ratings), but faces risks from margin pressure, legal scrutiny, and earnings misses. Revenue growth remains a key catalyst, though execution risks and investor sentiment headwinds warrant caution.
UGL trades at $50.61, down 3.43% in the last 24 hours amid a bearish technical signal. Key support lies at $49, with resistance at $51. The stock shows oversold conditions on short-term RSI but lacks fundamental data for valuation assessment. Recent news highlights gold market volatility driven by inflation data and geopolitical tensions, influencing sector sentiment.
The outlook remains cautious due to technical weakness and macroeconomic uncertainty. Opportunities exist if gold prices rebound, but risks include Fed rate hikes and inflation pressures. Investors should await financial disclosures for fundamental clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
